DANVERS, Mass.--(BUSINESS WIRE)--Medical device company Marine Polymer Technologies, Inc. announced that on September 16, 2010, the United States District Court for the District of New Hampshire entered an Order permanently enjoining HemCon, Inc. from infringing Marine Polymer’s United States Patent No. 6,864,245. The Order is the latest ruling in a patent infringement lawsuit, which was filed in March 2006 by Marine Polymer, concerning biocompatible polymers known in the industry as “p-GlcNAc.” The patented polymers are the essential ingredient of hemostatic products designed to prevent severe blood loss. Marine Polymer and HemCon both manufacture hemostatic products containing the patented technology, and the two companies directly compete in the civilian market. The permanent injunction entered against HemCon is effective as of September 16, 2010.
